Skin Cancer

Plant Extract Found To Kill Melanoma Tumors

Published in Cancer Weekly, February 12th, 2002

Credere Corp. of Southern California has announced a significant breakthrough in ongoing research into the treatment of melanoma with the use of the company's patented, purified plant compound, LP-9.

After 4 years of isolation, purification and in vitro testing, studies demonstrated direct antitumor activity in a wide range of cancers with 25-75% of cancerous cell growth inhibited, eliminated or both. Initial animal testing and toxicity studies demonstrated minimal toxicity and elimination of melanoma tumors in greater than 60% of test animals.

Isolation and testing of LP-9 for Credere was conducted at M.D. Anderson Cancer Center in Houston, Texas. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-02-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry